J. Wierda

发表

Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg-1.

B. Debaene, M. Blobner, K. Olkkola, 2000, British journal of anaesthesia.

Relationship between chemical structure and physicochemical properties of series of bulky organic cations and their hepatic uptake and biliary excretion rates.

J. Proost, D. Meijer, J. Wierda, 1997, The Journal of pharmacology and experimental therapeutics.

Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488).

J. Proost, J. Wierda, S. Schiere, 1999, Anesthesia and analgesia.

Pharmacokinetic and pharmacokinetic/-dynamic (PK/PD) relationship of Org 9488, the 3-desacetyl metabolite of Org 9487

J. Wierda, S. Schiere, H. Proost, 1997 .

Structure-pharmacokinetics relationship of series of aminosteroidal neuromuscular blocking agents in the cat.

J. Proost, D. Meijer, D. Meijer, 2000, The Journal of pharmacology and experimental therapeutics.

Good Clinical Research Practice guidelines and PK‐PD modelling without twitch stabilisation

J. Proost, D. Eleveld, A. de Haes, 2008, Acta anaesthesiologica Scandinavica.

Urinary, biliary and faecal excretion of rocuronium in humans.

J. Proost, L. Eriksson, R. Mirakhur, 2000, British journal of anaesthesia.

Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children.

T. Taivainen, J. Proost, O. Meretoja, 1997, British journal of anaesthesia.

Abstracts of doctoral theses

J. Wierda, E. Klinkenberg-Knol, 1991, Pharmaceutisch Weekblad.

Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.

J. Proost, J. Wierda, R. Mirakhur, 1996, British journal of anaesthesia.

Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure.

J. Wierda, R. Mirakhur, J. Wierda, 1993, British journal of anaesthesia.

Decreased number of acetylcholine receptors is the mechanism that alters the time course of muscle relaxants in myasthenia gravis: a study in a rat model

J. Proost, A. de Haes, M. Houwertjes, 2005, European journal of anaesthesiology.

Rocuronium for muscle relaxation in ambulatory patients

Tariq, J. Wierda, 2001 .

Structure-pharmacodynamic-pharmacokinetic relationships of steroidal neuromuscular blocking agents.

J. Proost, J. Wierda, J. Wierda, 1995, European journal of anaesthesiology. Supplement.

Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates.

J. Proost, J. Wierda, J. Wierda, 1993, Journal of chromatography.

Pharmacokinetics of rocuronium bromide in patients with and without renal failure.

R. Mirakhur, J. Wierda, R. Cooper, 1995, European journal of anaesthesiology. Supplement.

Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients.

C. Keller, J. Proost, H. Sparr, 1997, British journal of anaesthesia.

Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans.

J H Proost, J. Proost, J. Wierda, 1994, European journal of anaesthesiology. Supplement.

The pharmacokinetics and the pharmacokinetic-dynamic relationship of rocuronium bromide

J. Proost, J. Wierda, 1995 .

Early and late reversibility of rocuronium bromide.

J. Proost, J. Wierda, L. van den Broek, 1994, European journal of anaesthesiology. Supplement.

The Relationship Between Rate of Administration of an Intubating Dose of Rocuronium and Time to 50% and 90% Block at the Adductor Pollicis Muscle

D. Eleveld, A. de Haes, J. Wierda, 2004, Journal of clinical monitoring and computing.

Effect of vecuronium on the release of acetylcholine after nerve stimulation.

J. Wierda, G. van Santen, 2000, Journal of applied physiology.

A pharmacokinetic/pharmacodynamic model explaining the altered potency and time course of action of neuromuscular blocking agents in myasthenic patients

J. Proost, D. Meijer, J. Wierda, 1997 .

Pharmacokinetics of Rocuronium After Bolus and Continuous Infusion During Halothane Anaesthesia

R. Mirakhur, J. Wierda, H. Proost, 1996 .

Model to describe the degree of twitch potentiation during neuromuscular monitoring.

A. Kopman, J. Proost, D. Eleveld, 2004, British journal of anaesthesia.

The pulmonary first-pass uptake of five nondepolarizing muscle relaxants in the pig.

J. Proost, M. Houwertjes, J. Wierda, 1999, Anesthesiology.

Pharmacokinetic Aspects of the Onset of Action of Neuromuscular Blocking Agents

J. Proost, J. Wierda, 2000, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

Abstracts of papers and posters Meeting on Pharmaceutical Sciences

S. W. F. Omta, Gert Luurtsema, John Urquhart, 1993, Pharmacy World and Science.

Pharmacokinetics of Cyclosporine A After Intravenous and Oral Administration in Liver Transplant Patients Measured with High‐Performance Liquid Chromatography

W. Sluiter, D. Uges, J. Wierda, 1993, Therapeutic drug monitoring.